Theodore Lystig

Learn More
BACKGROUND The beneficial effects of pharmacotherapy for chronic obstructive pulmonary disease (COPD) are well established. However, there are few data for treatment in the early stages of the disease. We examined the effect of tiotropium on outcomes in a large subgroup of patients with moderate COPD. METHODS The Understanding Potential Long-Term Impacts(More)
BACKGROUND The changes in inspiratory capacity (IC) over time in chronic obstructive pulmonary disease (COPD) patients are unknown. The Understanding Potential Long-term Impacts on Function with Tiotropium (UPLIFT®) trial included IC measurements. METHODS IC analysis from UPLIFT® (N = 5992) was performed at 1 and 6 months, and every 6 months through 4(More)
  • 1